ZHAOKE INNOVATION
Similar Organizations
Atlantique Vendée Innovation
Atlantique Vendée Innovation is an investment firm based in France
Digital Innovation and Growth
Digital Innovation and Growth is an investment firm.
ILP Innovation
ILP Innovation is an investment firm.
Pennvention
Pennvention is an investment firm.
Zaoniao Jijin
Zaoniao Jijin is a investment firm.
Zheji Touzi
Zheji Touzi is an investment firm.
Zhi Gao Holding
Zhi Gao Holding is an investment firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-09 | Tigerweld | Zhaoke Innovation investment in Series A - Tigerweld | 1.46 M USD |
More informations about "Zhaoke Innovation"
Zhaoke Ophthalmology Announces 2024 Annual Results
Zhaoke is also preparing to resubmit a new drug application (“NDA”) for CsA Ophthalmic Gel in the near future. For the third flagship innovative drug TAB014 for wAMD, Zhaoke announced …See details»
Zhaoke Innovation - Crunchbase Investor Profile & Investments
Jan 9, 2019 Zhaoke Innovation is an investment firm. Lists Featuring This Company. Edit Lists Featuring This Company Section. Investors Active in Guangdong . 5,727 Number of …See details»
Hong Kong ophthalmic drugs pioneer sets its sights on …
Dec 23, 2021 Zhaoke Ophthalmology, a Hong Kong-listed company, is aiming to take a leading role in mainland China’s eye disease market as the country’s innovation ecosystem matures.See details»
Zhaoke Innovation - Investments, Portfolio & Company Exits
Jan 9, 2019 Zhaoke Innovation has invested in Tigerweld on Jan 9, 2019. This investment - Series A - Tigerweld - was valued at . obfuscated. obfuscated. How many investments has this …See details»
Zhaoke Ophthalmology Announces First Interim Results
The Company’s portfolio includes several potential blockbuster innovative drug candidates and Zhaoke Ophthalmology expects to commercialize some of the drugs from as early as 2022, …See details»
Revolutionizing eye care treatment with quality & innovation!
Oct 19, 2024 In conclusion, Zhaoke Ophthalmology’s unwavering dedication to innovation, excellence and collaboration has positioned it as a pioneering force in the field of ophthalmic …See details»
Lau Lit Fui – CSO & President, Zhaoke Ophthalmology
Aug 28, 2023 President and Chief Scientific Officer Lau Lit Fui outlines how the now HKEX-listed company's capital-raising efforts have evolved, the key areas in its comprehensive portfolio of innovative and generic treatments covering …See details»
Zhaoke Ophthalmology (fka China Ophthalmology Focus)
"China Ophthalmology Focus Ltd., founded in 2018 and located in Hong Kong is focused o the ophthalmic Asian market. The company has outlined that 21 research and development …See details»
Nevakar and zhaoke ophthalmology enter into licensing ... - Vyluma
Oct 20, 2020 Bridgewater, NJ (USA) and Hong Kong S.A.R., October 20, 2020 – Nevakar Inc. (“Nevakar”), a privately held, late-stage, biopharmaceutical company developing multiple …See details»
Zhaoke Ophthalmology - A Panacea Venture Portfolio …
Zhaoke has a comprehensive drug portfolio of innovative and generic treatments covering 6 major eye diseases across both the front and back of the eye including DED, myopia, presbyopia, wet AMD, DME and glaucoma. Zhaoke launched a …See details»
Zhaoke Ophthalmology Achieves Positive Topline Results from the …
Jan 2, 2025 Dr. Li Xiaoyi (Benjamin), Chairman of the Board, Executive Director and CEO of Zhaoke Ophthalmology, said, “The positive topline results from the Phase III trial of TAB014 …See details»
Nevakar/Zhaoke Ophthalmology Enter Licensing Agreement for …
Oct 20, 2020 We expect that with its focus on and local knowledge of ophthalmology and the strength of Zhaoke Ophthalmology’s regulatory and commercial organization, NVK-002 will …See details»
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited
Hong Kong Science & Technology Parks Corporation - Company Directory - Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited Company Directory INNOVISSee details»
Visus signs deal with Zhaoke to develop eye-drops across Asia
May 16, 2022 “We are pleased to partner with Zhaoke Ophthalmology, an innovation-focused company with a highly experienced commercial team and a robust research, clinical and …See details»
Nevakar and Zhaoke Ophthalmology Enter into Licensing …
Oct 20, 2020 Contacts. Investor Contacts for Nevakar: Marshall Woodworth Chief Financial Officer (908) 367-7413 Lisa M. Wilson (212) 452-2793 E: lwilson@insitecony.com Investor …See details»
S&C Advises Underwriters of Zhaoke Ophthalmology Spin-Off and …
May 19, 2021 Zhaoke Ophthalmology is an ophthalmic pharmaceutical company with a drug pipeline of 25 candidates, including 13 innovative drugs and 12 generic drugs. Its core …See details»
Nevakar and zhaoke ophthalmology enter into licensing …
Oct 20, 2020 Bridgewater, NJ (USA) and Hong Kong S.A.R., October 20, 2020 – Nevakar Inc. (“Nevakar”), a privately held, late-stage, biopharmaceutical company developing multiple …See details»
Podcast Series Episode 3: Zhaoke Ophthalmology 2021 Interim …
Zhaoke Ophthalmology submitted the ANDA in August 2019. This will be the first preservative free generic commercialized in China, which will help improve patients’ comfort levels during …See details»
Zhaoke Ophthalmology's IND Application for Potential First …
HONG KONG, Sept. 29, 2021 /PRNewswire/ -- Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or "the Company", SEHK: 6622), a leading ophthalmic pharmaceutical …See details»
Tech startup culture is not as innovative as founders may think
11 hours ago In our research, we identified 30 different cultural elements of companies.These include cultures of work-life balance, teamwork, authority, innovation, and compensation …See details»